+Search query
-Structure paper
Title | Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses. |
---|---|
Journal, issue, pages | Cell Chem Biol, Vol. 29, Page 774-, Year 2022 |
Publish date | Mar 9, 2021 (structure data deposition date) |
Authors | Napolitano, V. / Dabrowska, A. / Schorpp, K. / Mourao, A. / Barreto-Duran, E. / Benedyk, M. / Botwina, P. / Brandner, S. / Bostock, M. / Chykunova, Y. ...Napolitano, V. / Dabrowska, A. / Schorpp, K. / Mourao, A. / Barreto-Duran, E. / Benedyk, M. / Botwina, P. / Brandner, S. / Bostock, M. / Chykunova, Y. / Czarna, A. / Dubin, G. / Frohlich, T. / Holscher, M. / Jedrysik, M. / Matsuda, A. / Owczarek, K. / Pachota, M. / Plettenburg, O. / Potempa, J. / Rothenaigner, I. / Schlauderer, F. / Slysz, K. / Szczepanski, A. / Greve-Isdahl Mohn, K. / Blomberg, B. / Sattler, M. / Hadian, K. / Popowicz, G.M. / Pyrc, K. |
External links | Cell Chem Biol / PubMed:35021060 |
Methods | X-ray diffraction |
Resolution | 2.68 Å |
Structure data | PDB-7nt4: |
Chemicals | ChemComp-PRL: ChemComp-EDO: ChemComp-ZN: ChemComp-SO4: ChemComp-HOH: |
Source |
|
Keywords | HYDROLASE / Drug repurposing / SCoV2-PLpro inhibitor |